The consumption of caffeine (2), which is a weakly potent and non-selective AR antagonist (Figure 1), was found to protect from PD and AD as demonstrated in a number of animal models as well as in large epidemiological studies in humans (Chen and Chern, 2011; Flaten et al., 2014). This evidence concerns the gene AR and Parkinson disease.